Skip to content
Home/Companies/Biotech/Bilhi Genetics

Bilhi Genetics

Biotech·France·Exited 2026·Held 10yr
Entry
2016
Hold
10yr
Exit
2026

Who owns Bilhi Genetics?

Bilhi Genetics is a French Biotech company, formerly owned by CapHorn, exited in 2026. No current private equity owner is on file.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
CapHorn
Investor
CapHorn
CapHorn Invest 1 · 2011 · VC

Key facts

HQFrance
SectorBiotech
Exit Year
2026

More from CapHorn Invest 1

Other portfolio companies in the same fund.

Saagie
Exited 2025
Data & AnalyticsFrance· 2016
to Scaleway
Boxtal
Exited 2021
LogisticsFrance· 2013
to La Poste
Exaqtworld
Exited 2024
IndustrialsFrance· 2013
to ITQ Group

More CapHorn portfolio companies

From the same investor, across funds.

Happywait
Active
ConsumerFrance
Impress
Impress
Active
HealthTechSpain
Innovorder
Innovorder
Active
SaaSFrance
OCUS
OCUS
Active
E-commerceFrance
Osivax
Active
BiotechFrance
PEP-Therapy
Active
BiotechFrance

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Bilhi Genetics?

Bilhi Genetics was formerly owned by CapHorn, exited in 2026. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue